FDA approves new hepatitis C drug, Harvoni
from Kaiser Health News
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063